This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Targeting of focal adhesion kinase enhances the immunogenic cell death of PEGylated liposome doxorubicin to optimize therapeutic responses of immune checkpoint blockade
Journal of Experimental & Clinical Cancer Research Open Access 19 February 2024
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Original articles
Baruch, E. N. et al. Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients. Science 371, 602–609 (2021)
Davar, D. & Dzutsev, A. K. et al. Fecal microbiota transplant overcomes resistance to anti–PD-1 therapy in melanoma patients. Science 371, 595–602 (2021)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
York, A. Overcoming hurdles in cancer immunotherapy. Nat Rev Cancer 21, 214–215 (2021). https://doi.org/10.1038/s41568-021-00343-3
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41568-021-00343-3
This article is cited by
-
Targeting of focal adhesion kinase enhances the immunogenic cell death of PEGylated liposome doxorubicin to optimize therapeutic responses of immune checkpoint blockade
Journal of Experimental & Clinical Cancer Research (2024)